Philippe Müller

1.7k total citations · 1 hit paper
32 papers, 1.0k citations indexed

About

Philippe Müller is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Philippe Müller has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Philippe Müller's work include Coronary Interventions and Diagnostics (8 papers), Cardiac Valve Diseases and Treatments (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Philippe Müller is often cited by papers focused on Coronary Interventions and Diagnostics (8 papers), Cardiac Valve Diseases and Treatments (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Philippe Müller collaborates with scholars based in United Kingdom, United States and Netherlands. Philippe Müller's co-authors include Stefanie M. Brendecke, Tobias Goldmann, Marco Prinz, Yochai Wolf, Simon Yona, Ori Staszewski, Tom Luedde, Peter Wieghofer, Mathias Heikenwälder and Katrin Kierdorf and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Neuroscience.

In The Last Decade

Philippe Müller

31 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation

2013 516 citations Tobias Goldmann, Peter Wieghofer et al. Nature Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Müller United Kingdom	12	415	324	187	178	128	32	1.0k
Benoît Thezé France	17	204 0.5×	116 0.4×	54 0.3×	306 1.7×	59 0.5×	25	948
Andreas Steinbrecher Germany	18	94 0.2×	251 0.8×	40 0.2×	565 3.2×	183 1.4×	52	1.6k
Virginie Tardif United States	16	166 0.4×	257 0.8×	34 0.2×	509 2.9×	39 0.3×	27	1.1k
Junying Zheng United States	17	101 0.2×	96 0.3×	111 0.6×	330 1.9×	40 0.3×	26	823
Sara Bar‐Yehuda Israel	24	133 0.3×	299 0.9×	267 1.4×	872 4.9×	125 1.0×	33	2.0k
Aya Narita Japan	14	262 0.6×	37 0.1×	177 0.9×	280 1.6×	107 0.8×	42	840
Filip Kukulski Canada	19	61 0.1×	180 0.6×	61 0.3×	298 1.7×	113 0.9×	21	1.2k
Elisa Orioli Italy	17	101 0.2×	260 0.8×	54 0.3×	408 2.3×	141 1.1×	21	1.2k
Marc H. Levin United States	23	103 0.2×	84 0.3×	46 0.2×	544 3.1×	77 0.6×	49	1.5k
Yumin Oh United States	18	114 0.3×	104 0.3×	48 0.3×	485 2.7×	139 1.1×	29	1.2k

Countries citing papers authored by Philippe Müller

Since Specialization

Citations

This map shows the geographic impact of Philippe Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Müller more than expected).

Fields of papers citing papers by Philippe Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Müller. The network helps show where Philippe Müller may publish in the future.

Co-authorship network of co-authors of Philippe Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Müller. A scholar is included among the top collaborators of Philippe Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Müller. Philippe Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aicher, Helena, Philippe Müller, Maxim Puchkov, et al.. (2025). Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study. Biomedicine & Pharmacotherapy. 184. 117908–117908. 3 indexed citations

Müller, Philippe, et al.. (2023). Response to ‘Eruptive Keratoacanthomas Associated with Dupilumab Therapy’. SHILAP Revista de lepidopterología. 3(3). e197–e197.

Chandrasekhar, Jaya, Deborah N. Kalkman, Pier Woudstra, et al.. (2020). Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent. Catheterization and Cardiovascular Interventions. 98(3). 503–510. 6 indexed citations

Wilhelm, Konrad, et al.. (2019). Characterization of Flow-Caused Intrarenal Pressure Conditions During Percutaneous Nephrolithotomy In Vitro. Journal of Endourology. 33(3). 235–241. 9 indexed citations

Kalkman, Deborah N., Pier Woudstra, Ian Menown, et al.. (2019). Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry. Cardiovascular revascularization medicine. 21(5). 567–570. 2 indexed citations

Schoeb, Dominik S., et al.. (2018). Robotic waterjet wound debridement – Workflow adaption for clinical application and systematic evaluation of a novel technology. PLoS ONE. 13(9). e0204315–e0204315. 8 indexed citations

Kalkman, Deborah N., Pier Woudstra, Ian Menown, et al.. (2018). Three‐year clinical outcomes after dual‐therapy COMBO stent placement: Insights from the REMEDEE registry. Catheterization and Cardiovascular Interventions. 94(3). 342–347. 7 indexed citations

Woudstra, Pier, Deborah N. Kalkman, Peter den Heijer, et al.. (2016). 1-Year Results of the REMEDEE Registry. JACC: Cardiovascular Interventions. 9(11). 1127–1134. 27 indexed citations

Winter, Robbert J. de, Peter den Heijer, Ian Menown, et al.. (2015). TCT-63 One Year Results Of The REMEDEE Registry: Clinical Outcomes After Deployment Of The Abluminal Sirolimus Coated Bio-Engineerd Stent In A Multicenter, Prospective Post Market Registry. Journal of the American College of Cardiology. 66(15). B28–B28. 1 indexed citations

10.

Goldmann, Tobias, Peter Wieghofer, Philippe Müller, et al.. (2013). A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nature Neuroscience. 16(11). 1618–1626. 516 indexed citations breakdown →

11.

Cohen, Bernard, Mingjia Dai, Jean Laurens, et al.. (2011). Motion sickness on tilting trains. The FASEB Journal. 25(11). 3765–3774. 10 indexed citations

12.

Deloumeaux, Jacqueline, Mustapha Maachi, I. Lamaury, et al.. (2010). Adiponectin and leptin in Afro-Caribbean men and women with HIV infection: Association with insulin resistance and type 2 diabetes. Diabetes & Metabolism. 37(2). 98–104. 5 indexed citations

13.

Müller, Philippe, Thiérry Prazuck, Eric Peyrouse, et al.. (2010). Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulation. AIDS. 24(15). 2375–2380. 38 indexed citations

14.

Bonfanti, Jean‐François, Christophe Meyer, Jérôme Fortin, et al.. (2008). Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121). Journal of Medicinal Chemistry. 51(4). 875–896. 76 indexed citations

15.

Freitag, Ruth, et al.. (2007). Integration of Bacteria Capture via Filtration and in Situ Lysis for Recovery of Plasmid DNA under Industry-Compatible Conditions. Biotechnology Progress. 23(4). 895–903. 6 indexed citations

16.

Chéret, Antoine, et al.. (2006). Angiomatose bacillaire au cours du SIDA. Annales de Dermatologie et de Vénéréologie. 133(5). 498–499. 1 indexed citations

17.

Freitag, Ruth, et al.. (2006). Capture of Bacteria from Fermentation Broth by Body Feed Filtration: A Solved Problem?. Biotechnology Progress. 22(2). 471–483. 9 indexed citations

18.

Angibaud, Patrick, Ann Devine, David W. End, et al.. (2003). 5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(9). 1543–1547. 27 indexed citations

19.

Angibaud, Patrick, David W. End, Eddy Freyne, et al.. (2003). Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(24). 4365–4369. 19 indexed citations

20.

Strobel, M, Philippe Müller, I. Lamaury, & François Rouet. (2001). Dengue Fever: A Harmful Disease in Patients with Thrombocytopenia?. Clinical Infectious Diseases. 33(4). 580–581. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact